NYSEARCA:FBT

First Trust NYSE Arca Biotechnology Index Fund (FBT) Price, Holdings, & News

$142.93
+1.25 (+0.88%)
(As of 04/22/2024 ET)
Today's Range
$141.51
$143.89
50-Day Range
$141.52
$155.99
52-Week Range
$130.27
$161.41
Volume
18,923 shs
Average Volume
28,770 shs
Market Capitalization
$1.09 billion
Assets Under Management
$1.08 billion
Dividend Yield
0.00%
Net Expense Ratio
0.55%
FBT stock logo

About First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.

FBT Stock Price History

FBT ETF News Headlines

First Trust NYSE Arca Biotechnology Index Fund (FBT)
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
NYSE Arca Major Market Index
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
NYSE Arca Gold BUGS Index
See More Headlines
Receive FBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
First Trust
Fund Name
First Trust NYSE Arca Biotechnology Index Fund
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:FBT
Inception Date
6/19/2006
Fund Manager
Daniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE Arca Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
31

Fund Statistics

Assets Under Management
$1.08 billion
Average Daily Volume
$24,390.20
Discount/Premium
-0.08%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
RBC Capital Markets

Options

Optionable
Optionable
Options Volume
3
Put Options
3
Call Options
3

Miscellaneous

Beta
0.85
Creation Unit
50,000
Creation Fee
$500.00
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

First Trust NYSE Arca Biotechnology Index Fund Expenses

TypeFBTHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.40%0.56%0.54%0.50%0.51%
Other Expenses0.15%0.40%0.54%0.64%0.58%
Total Expense0.55%0.72%0.70%0.74%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.68%-0.57%
Net Expense0.55%0.60%0.60%0.57%0.58%

First Trust NYSE Arca Biotechnology Index Fund (FBT) Holdings & Exposure


FBT ETF - Frequently Asked Questions

How have FBT shares performed in 2024?

First Trust NYSE Arca Biotechnology Index Fund's stock was trading at $158.06 on January 1st, 2024. Since then, FBT shares have decreased by 9.6% and is now trading at $142.93.
View the best growth stocks for 2024 here
.

What does FBT invest in?

First Trust NYSE Arca Biotechnology Index Fund is a equity fund issued by First Trust. FBT focuses on health care investments and follows the NYSE Arca Biotechnology Index. The fund's investments total to approximately $1.08 billion assets under management.

What stocks does First Trust NYSE Arca Biotechnology Index Fund hold?
What is the management fee for First Trust NYSE Arca Biotechnology Index Fund?

First Trust NYSE Arca Biotechnology Index Fund's management fee is 0.40% and has other expenses of 0.15%. The net expense ratio for FBT is 0.55%.

What other stocks do shareholders of First Trust NYSE Arca Biotechnology Index Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology Index Fund investors own include Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Walt Disney (DIS), Annaly Capital Management (NLY), ONEOK (OKE), Valero Energy (VLO), AbbVie (ABBV), Broadcom (AVGO) and Bristol-Myers Squibb (BMY).

Who are First Trust NYSE Arca Biotechnology Index Fund's major shareholders?

First Trust NYSE Arca Biotechnology Index Fund's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Raymond James Financial Services Advisors Inc. (1.57%), Raymond James & Associates (1.46%), Quad Cities Investment Group LLC (0.11%), Juncture Wealth Strategies LLC (0.11%), SignalPoint Asset Management LLC (0.07%) and GoalVest Advisory LLC (0.06%).

How do I buy shares of First Trust NYSE Arca Biotechnology Index Fund?

Shares of FBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:FBT) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners